Curious to see your top suppliers emissions?
Book a demo for a pilot project
Hester Biosciences
Pharmaceutical Preparation ManufacturingIndiaASX: WEL.AX
Last verified 11 days agoelevationcoffeefarm.com
Hester Biosciences Limited, commonly referred to as Hester Biosciences, is a prominent player in the pharmaceutical preparation manufacturing industry, headquartered in India. Established in 1987, the company has grown to become a leading provider of vaccines and biological products primarily for the poultry sector, with a strong presence across India and expanding operations in other regions.
Specialising in the development and production of vaccines, Hester Biosciences is recognised for its innovative approach and high-quality standards, which set it apart in the competitive pharmaceutical manufacturing landscape. The company's core offerings include vaccines for poultry health management, contributing significantly to disease prevention and food security.
With a reputation for reliability and excellence, Hester Biosciences has achieved notable milestones in its journey, cementing its position as a key player in the Indian pharmaceutical preparation industry. Its commitment to quality and innovation continues to drive growth and industry recognition.
19
DitchCarbon score
-21 vs industry average
Hester Biosciences’s score of 19 is lower than 23% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Hester Biosciences?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2026
2020202120222023202420252026
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Hester Biosciences's reported carbon emissions
Hester Biosciences, an Indian pharmaceutical preparation manufacturer, reported a total of approximately 9.92 million kg CO2e in Scope 1 and Scope 2 emissions for the fiscal year 2023. This figure represents a slight increase from approximately 7.26 million kg CO2e reported for fiscal year 2022.
For fiscal year 2023, Hester Biosciences' Scope 1 emissions amounted to about 1.44 million kg CO2e, while Scope 2 emissions were approximately 8.48 million kg CO2e. In the preceding year, 2022, Scope 1 emissions stood at roughly 1.40 million kg CO2e, and Scope 2 emissions were approximately 5.86 million kg CO2e.
The company's reporting indicates a focus on Scope 1 and Scope 2 emissions, with Scope 3 emissions data not yet disclosed. Hester Biosciences has not publicly detailed specific reduction targets or joined initiatives like the Science Based Targets initiative (SBTi).
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Hester Biosciences’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Hester Biosciences yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Hester Biosciences11 days ago
19
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more